The key is comparing actual evidence, not just marketing promises
Ip added the study has paved the way for a larger phase three randomised trial to confirm the drug's neuroprotective potential
Researchers tested whether combining zalfermin, an experimental medicine designed to improve the body's metabolism, with GLP-1 receptor agonist, could reverse liver fibrosis more effectively than either treatment alone
For most patients, it resolves substantially after the first few weeks of a given dose
Currently, neither Saxenda nor Wegovy is subsidized by the Pharmaceutical Benefits Scheme (PBS) specifically for obesity treatment, though Ozempic (the 1mg semaglutide version) is available on the PBS for diabetes management
4 Oral - Aquatic Chronic 2 - Met